We are live on ! Find out more
CCS

Crosspoint Capital Strategies Portfolio holdings

AUM $50.4M
1-Year Est. Return 15.37%
This Fund
S&P 500
This Quarter Est. Return
+1.95%
1 Year Est. Return
-15.37%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$381M
AUM Growth
+$295M
Cap. Flow
+$275M
Cap. Flow %
72.22%
Top 10 Hldgs %
21.15%
Holding
1,442
New
651
Increased
225
Reduced
142
Closed
422

Sector Composition

Rank Sector Weight
1 Miscellaneous 53.96%
2 Consumer Discretionary 8.59%
3 Healthcare 6.3%
4 Financials 5.92%
5 Consumer Staples 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPT
626
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$15K ﹤0.01%
+218
New +$7.67K
NXH
627
Neighborhood Intelligence Inc
NXH
$376M
$15K ﹤0.01%
+799
New +$8.74K
EMN icon
628
Eastman Chemical
EMN
$8.31B
$15K ﹤0.01%
195
+187
+2,338% +$13.1K
HTGC icon
629
Hercules Capital
HTGC
$3.28B
$15K ﹤0.01%
+1,000
New +$11.3K
M icon
630
Macy's
M
$5.92B
$15K ﹤0.01%
320
-2,080
-87% -$90.1K
PCEF icon
631
Invesco CEF Income Composite ETF
PCEF
$814M
$15K ﹤0.01%
+639
New +$13.7K
PFM icon
632
Invesco Dividend Achievers ETF
PFM
$804M
$15K ﹤0.01%
+703
New +$14.5K
SCHF icon
633
Schwab International Equity ETF
SCHF
$69.6B
$15K ﹤0.01%
1,036
-1,314
-56% -$18.8K
STZ icon
634
Constellation Brands
STZ
$22.4B
$15K ﹤0.01%
156
+81
+108% +$11.2K
TUR icon
635
iShares MSCI Turkey ETF
TUR
$223M
$15K ﹤0.01%
+280
New +$11.1K
UPGD icon
636
Invesco Bloomberg Analyst Rating Improvers ETF
UPGD
$120M
$15K ﹤0.01%
+425
New +$14.3K
PXD
637
DELISTED
Pioneer Natural Resource Co.
PXD
$15K ﹤0.01%
+100
New +$13.7K
BBBY
638
DELISTED
Bed Bath & Beyond Inc
BBBY
$15K ﹤0.01%
200
-44
-18% -$2.44K
EEP
639
DELISTED
Enbridge Energy Partners
EEP
$15K ﹤0.01%
385
-1,115
-74% -$27.9K
ANDV
640
DELISTED
Andeavor
ANDV
$15K ﹤0.01%
200
+176
+733% +$19K
BLS
641
DELISTED
BELLSOUTH CORPORATION
BLS
$15K ﹤0.01%
+317
New +$15K
VNR
642
DELISTED
Vanguard Natural Resources, LLC
VNR
$15K ﹤0.01%
+1,000
New +$6.11K
CNI icon
643
Canadian National Railway
CNI
$76.5B
$14K ﹤0.01%
+200
New +$11.7K
ETW
644
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.08B
$14K ﹤0.01%
+1,292
New +$14.8K
KBR icon
645
KBR
KBR
$4.81B
$14K ﹤0.01%
+845
New +$15.5K
NRT
646
North European Oil Royalty Trust
NRT
$79.1M
$14K ﹤0.01%
+1,175
New +$10.3K
PBT
647
Permian Basin Royalty Trust
PBT
$1.57B
$14K ﹤0.01%
+1,475
New +$9.12K
RSP icon
648
Invesco S&P 500 Equal Weight ETF
RSP
$99.8B
$14K ﹤0.01%
+170
New +$13.2K
TJX icon
649
TJX Companies
TJX
$148B
$14K ﹤0.01%
400
-15,120
-97% -$538K
HBMD
650
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
$14K ﹤0.01%
+1,230
New +$16.6K

Similar funds

Crosspoint Capital Strategies's Q4 2015 Portfolio in Review

As of Q4 2015, Crosspoint Capital Strategies held 1,442 positions worth $381M, up 342% from $86.2M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Crosspoint Capital Strategies deployed $275M of net new capital in Q4 2015, opening 651 new positions and adding to 225 existing holdings. Its largest new stake was La-Z-Boy: 559,318 shares worth $15M.

By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Air Methods Corp, an estimated $2.6M trimmed.

  • Crosspoint Capital Strategies's largest Q4 2015 buy was La-Z-Boy: 559,318 shares worth $15M.
  • Crosspoint Capital Strategies added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2015, an estimated $13.2M increase.
  • Crosspoint Capital Strategies's biggest Q4 2015 reduction was Air Methods Corp, cutting an estimated $2.6M.
  • Crosspoint Capital Strategies fully exited Dorchester Minerals in Q4 2015, selling an estimated $2.93M.
  • Crosspoint Capital Strategies's ten largest holdings make up 21% of its $381M portfolio in Q4 2015.
  • Crosspoint Capital Strategies opened 651 new positions and closed 422 in Q4 2015.
  • Crosspoint Capital Strategies's portfolio value rose 342% quarter-over-quarter to $381M.

Based on Crosspoint Capital Strategies's 13F filing for Q4 2015, filed 16 Feb 2016.